Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Ginekologia Polska
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 88, No 5 (2017)
Research paper
Published online: 2017-05-31
View PDF Download PDF file View HTML
Get Citation

IL16 and IL18 gene polymorphisms in women with gestational diabetes

Maciej Tarnowski1, Alicja Wieczorek2, Violetta Dziedziejko3, Krzysztof Safranow3, Przemysław Ustianowski4, Zbigniew Celewicz4, Andrzej Pawlik1
DOI: 10.5603/GP.a2017.0047
·
Pubmed: 28580570
·
Ginekol Pol 2017;88(5):249-254.
Affiliations
  1. Department of Physiology, Pomeranian Medical University, Szczecin, Poland 2”For-Dent” Medical Center, Pyrzyce, Poland, Poland
  2. ”For-Dent” Medical Center, Pyrzyce, Poland, Poland
  3. Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland
  4. Department of Perinatology, Obstetrics and Gynecology, Pomeranian Medical University, Szczecin, Poland

open access

Vol 88, No 5 (2017)
ORIGINAL PAPERS Obstetrics
Published online: 2017-05-31

Abstract

Objectives: Gestational diabetes mellitus is a carbohydrate intolerance that occurs during pregnancy. Various inflammatory mediators are considered to be risk factors leading to GDM development. Among them are pro-inflammatory cytokines, such as IL16 and IL18. The aim of this study was to examine the association between IL16 and IL18 polymorphisms and GDM.

Material and methods: This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). All samples were genotyped in duplicate using allelic discrimination assays with TaqMan® probes.

Results: We observed that there was a decreased frequency of IL16 rs4778889 CC genotype carriers among women with GDM (CC vs. CT + TT: OR = 0.14; 95% CI = 0.02–1.15; p = 0.034). However, there was no significant difference in the distri­bution of alleles (C vs. T: OR = 0.81; 95% CI = 0.54–1.21; p = 0.30). There was a decreased frequency of the IL18 rs187238 G allele among GDM women (G vs. C: OR = 0.71; 95% CI = 0.53–0.96; p = 0.027). We also observed a decreased frequency of the IL18 rs1946518 T allele among women with GDM; however, this difference had only borderline statistical significance. We observed an association between IL18 rs187238, rs1946518 and BMI in pregnant women.

Conclusions: The results of this study suggest that IL18 rs187238 and rs1946518 polymorphisms may be associated with an increased risk of GDM as well as with BMI in pregnant women.

Abstract

Objectives: Gestational diabetes mellitus is a carbohydrate intolerance that occurs during pregnancy. Various inflammatory mediators are considered to be risk factors leading to GDM development. Among them are pro-inflammatory cytokines, such as IL16 and IL18. The aim of this study was to examine the association between IL16 and IL18 polymorphisms and GDM.

Material and methods: This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). All samples were genotyped in duplicate using allelic discrimination assays with TaqMan® probes.

Results: We observed that there was a decreased frequency of IL16 rs4778889 CC genotype carriers among women with GDM (CC vs. CT + TT: OR = 0.14; 95% CI = 0.02–1.15; p = 0.034). However, there was no significant difference in the distri­bution of alleles (C vs. T: OR = 0.81; 95% CI = 0.54–1.21; p = 0.30). There was a decreased frequency of the IL18 rs187238 G allele among GDM women (G vs. C: OR = 0.71; 95% CI = 0.53–0.96; p = 0.027). We also observed a decreased frequency of the IL18 rs1946518 T allele among women with GDM; however, this difference had only borderline statistical significance. We observed an association between IL18 rs187238, rs1946518 and BMI in pregnant women.

Conclusions: The results of this study suggest that IL18 rs187238 and rs1946518 polymorphisms may be associated with an increased risk of GDM as well as with BMI in pregnant women.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

polymorphism, SNP, gestational diabetes, genes, metabolism

About this article
Title

IL16 and IL18 gene polymorphisms in women with gestational diabetes

Journal

Ginekologia Polska

Issue

Vol 88, No 5 (2017)

Article type

Research paper

Pages

249-254

Published online

2017-05-31

Page views

2118

Article views/downloads

2048

DOI

10.5603/GP.a2017.0047

Pubmed

28580570

Bibliographic record

Ginekol Pol 2017;88(5):249-254.

Keywords

polymorphism
SNP
gestational diabetes
genes
metabolism

Authors

Maciej Tarnowski
Alicja Wieczorek
Violetta Dziedziejko
Krzysztof Safranow
Przemysław Ustianowski
Zbigniew Celewicz
Andrzej Pawlik

References (33)
  1. Kim C. Gestational diabetes: risks, management, and treatment options. Int J Womens Health. 2010; 2: 339–351.
    CrossRefPubMed
  2. Barbour LA, McCurdy CE, Hernandez TL, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007; 30 Suppl 2: S112–S119.
    CrossRefPubMed
  3. Wielgoś M, Bomba-Opoń D, Czajkowski K, et al. Towards a European Consensus on Gestational Diabetes Mellitus: A Pragmatic Guide for Diagnosis, Management, and Care. The Polish Diabetes in Pregnancy Study Group and FIGO. Ginekol Pol. 2017; 88(1): 46–49.
    CrossRefPubMed
  4. Grabowska K, Stapińska-Syniec A, Saletra A, et al. Labour in women with gestational diabetes mellitus. Ginekol Pol. 2017; 88(2): 81–86.
    CrossRefPubMed
  5. Michalak-Wojnowska M, Gorczyca-Siudak D, Gorczyca T, et al. Association between rs7901695 and rs7903146 polymorphisms of the TCF7L2 gene and gestational diabetes in the population of Southern Poland. Ginekol Pol. 2016; 87(11): 745–750.
    CrossRefPubMed
  6. Hrolfsdottir L, Schalkwijk CG, Birgisdottir BE, et al. Maternal diet, gestational weight gain, and inflammatory markers during pregnancy. Obesity (Silver Spring). 2016; 24(10): 2133–2139.
    CrossRefPubMed
  7. Kalagiri RR, Carder T, Choudhury S, et al. Inflammation in Complicated Pregnancy and Its Outcome. Am J Perinatol. 2016; 33(14): 1337–1356.
    CrossRefPubMed
  8. Abell SK, De Courten B, Boyle JA, et al. Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus. Int J Mol Sci. 2015; 16(6): 13442–13473.
    CrossRefPubMed
  9. Mir M, Rostami A, Hormozi M. Comparison of serum levels of IL-18 in peripheral blood of patients with type II diabetes with nephropathy clinical protests and patients with type II diabetes without nephropathy clinical protests. Diabetes Metab Syndr. 2016 [Epub ahead of print].
    CrossRefPubMed
  10. Wedekind L, Belkacemi L. Altered cytokine network in gestational diabetes mellitus affects maternal insulin and placental-fetal development. J Diabetes Complications. 2016; 30(7): 1393–1400.
    CrossRefPubMed
  11. Syngelaki A, Visser GHA, Krithinakis K, et al. First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation. Metabolism. 2016; 65(3): 131–137.
    CrossRefPubMed
  12. Dziedziejko V, Kurzawski M, Paczkowska E, et al. The impact of IL18 gene polymorphisms on mRNA levels and interleukin-18 release by peripheral blood mononuclear cells. Postepy Hig Med Dosw (Online). 2012; 66: 409–414.
    PubMed
  13. Buraczynska M, Ksiazek K, Zukowski P, et al. Interleukin-18 gene polymorphism and risk of CVD in older patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016; 121: 178–183.
    CrossRefPubMed
  14. Li LL, Deng XF, Li JP, et al. Association of IL-18 polymorphisms with rheumatoid arthritis: a meta-analysis. Genet Mol Res. 2016; 15(1).
    CrossRefPubMed
  15. Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3): 676–682.
    CrossRefPubMed
  16. Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001; 112(1-2): 146–152.
    PubMed
  17. Khripko OP, Sennikova NS, Lopatnikova JA, et al. Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediators Inflamm. 2008; 2008: 309721.
    CrossRefPubMed
  18. Vendrame F, Cataldo D, Ciarlo L, et al. In type 1 diabetes immunocompetent cells are defective in IL-16 secretion. Scand J Immunol. 2012; 75(1): 127–128.
    CrossRefPubMed
  19. Meagher C, Beilke J, Arreaza G, et al. Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism. Diabetes. 2010; 59(11): 2862–2871.
    CrossRefPubMed
  20. Akbarzadeh M, Eftekhari MH, Dabbaghmanesh MH, et al. Serum IL-18 and hsCRP correlate with insulin resistance without effect of calcitriol treatment on type 2 diabetes. Iran J Immunol. 2013; 10(3): 167–176.
    CrossRefPubMed
  21. Gomes CP, Torloni MR, Gueuvoghlanian-Silva BY, et al. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol. 2013; 69(6): 545–557.
    CrossRefPubMed
  22. Rădulescu C, Bacârea A, Huțanu A, et al. Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia. Mediators Inflamm. 2016; 2016: 3027363.
    CrossRefPubMed
  23. Hwang JHa, Lee MiJ, Seok OS, et al. Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies. Cytokine. 2010; 49(1): 95–101.
    CrossRefPubMed
  24. Hsu TY, Lin H, Lan KC, et al. High interleukin-16 concentrations in the early second trimester amniotic fluid: an independent predictive marker for preterm birth. J Matern Fetal Neonatal Med. 2013; 26(3): 285–289.
    CrossRefPubMed
  25. Kuzmicki M, Telejko B, Zonenberg A, et al. Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res. 2008; 40(8): 556–560.
    CrossRefPubMed
  26. Fatima SS, Alam F, Chaudhry B, et al. Elevated levels of chemerin, leptin, and interleukin-18 in gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2017; 30(9): 1023–1028.
    CrossRefPubMed
  27. Elneam AI, Mansour NM, Zaki NA, et al. Serum Interleukin-18 and Its Gene Haplotypes Profile as Predictors in Patients with Diabetic Nephropathy. Open Access Maced J Med Sci. 2016; 4(3): 324–328.
    CrossRefPubMed
  28. Lee YHo, Kim JH, Song GG. Interleukin-18 promoter -607 C/A and -137 G/C polymorphisms and susceptibility to type 1 diabetes: A meta-analysis. Hum Immunol. 2015; 76(8): 537–545.
    CrossRefPubMed
  29. Li J, Wu S, Wang MR, et al. Association of the interleukin-18 -137 C/G, -607 A/C polymorphisms with type 1 diabetes: A meta-analysis. Biomed Rep. 2014; 2(1): 57–62.
    CrossRefPubMed
  30. Opstad TB, Pettersen AÅ, Arnesen H, et al. Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol. 2011; 10: 110.
    CrossRefPubMed
  31. Huang Y, Xu M, Hong J, et al. -607 C/A polymorphism in the promoter of IL-18 gene is associated with 2 h post-loading plasma glucose level in Chinese. Endocrine. 2010; 37(3): 507–512.
    CrossRefPubMed
  32. Kim HL, Cho SO, Kim SY, et al. Association of interleukin-18 gene polymorphism with body mass index in women. Reprod Biol Endocrinol. 2012; 10: 31.
    CrossRefPubMed
  33. Thompson SR, Sanders J, Stephens JW, et al. A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease. Metabolism. 2007; 56(5): 662–669.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl